LH - CIK 0000920148
The table below shows LABORATORY CORP OF AMERICA HOLDINGS's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|
| Operating cash flow | $191.50M | $18.50M | -$29.80M | $121.20M | - | - |
| Capital expenditure | $121.00M | $126.00M | $133.80M | $78.20M | - | - |
| Investing cash flow | -$322.10M | -$336.00M | -$393.10M | -$99.70M | - | - |
| Dividends paid | $61.20M | $61.60M | $62.10M | $64.40M | - |
LABORATORY CORP OF AMERICA HOLDINGS reported operating cash flow of $1.64B for fiscal year 2025. That is up 3.4% from $1.59B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $1.20B (FY 2016) to $1.64B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | $98.00M | $0.00 | - | - | $800.00M | $400.00M |
| Financing cash flow | $580.50M | -$839.70M | -$11.70M | -$60.60M | - | - |